How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?

Clinical trial NCT06369077 · TERMINATED

Trial details

NCT number: NCT06369077
Sponsor: CT Glaucoma Associates
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma, Open-Angle Glaucoma; Drugs

Start date: 2024-04-22
Primary completion: 2024-07-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.